Segment & Geographic Data
Reported Filing Data
API & CSV Delivery
Concord Medical Services Holdings Ltd's Business Segments
Concord Medical Services Holdings Ltd's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of 2025 ((Dec 31 2025))
Reportable Segments
2
Largest Segment
Hospital Segment
Total Revenue
$ 66
Regions Reported
-
Annual Results
Revenue Share by Reportable Segment - FY2025
- Hospital Segment0%
- Network Segment0%
Revenue by Reportable Segment - FY2025
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Hospital Segment | $ 374 | - |
| Network Segment | $ 87 | - |
Revenue by Product & Service Category - FY2025
- Services and Other Revenues0%
- Health Care0%
- Medicine Income0%
- Medical Solution0%
- Management and Technical Services15.5%
- Equipment Leasing Revenues9.4%
Revenue by Product & Service Category - FY2025
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Services and Other Revenues | $ 375 | - |
| Health Care | $ 294 | - |
| Medicine Income | $ 80 | - |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
3 more categories available
Sign in to unlock the full Concord Medical Services Holdings Ltd dataset.
Description of Concord Medical Services Holdings Ltd
Concord Medical Services Holdings Ltd is a leading specialized hospital management company in China that operates premium cancer hospitals and provides advanced cancer treatment and healthcare services. It was incorporated in 2007 and is headquartered in Beijing, China.
Concord Medical Services Holdings Ltd primarily focuses on the operation and management of radiotherapy and diagnostic imaging centers. The company's flagship brand, Concord Cancer Hospital, offers comprehensive cancer treatment and diagnostic services. It collaborates with renowned domestic and international hospitals and medical institutions to provide patients with cutting-edge medical technologies and treatment options.
The company's business model involves leasing or acquiring medical equipment and diagnostic machines, which it then operates and manages in its hospitals and centers. It also provides technical support, training, and consulting services to its partner hospitals, thereby promoting the adoption of advanced medical technologies and best practices in the industry.
Concord Medical Services Holdings Ltd owns and operates a network of hospitals and centers across major cities in China, including Beijing, Shanghai, and Guangzhou. These facilities are staffed by highly trained medical professionals, including doctors, nurses, and technicians, who specialize in cancer treatment and care. The company ensures that its hospitals and centers are equipped with state-of-the-art medical equipment and technologies to deliver precise and effective treatment to its patients.
In addition to its hospital management services, Concord Medical Services Holdings Ltd operates a patient-centered healthcare ecosystem. This ecosystem integrates online and offline healthcare services to provide patients with a convenient and comprehensive healthcare experience. Through its online platform, patients can access medical information, make appointments, receive telemedicine consultations, and order medicines or medical supplies.
Furthermore, Concord Medical Services Holdings Ltd actively engages in medical research and development. The company collaborates with renowned medical institutions, universities, and research organizations to conduct clinical trials, develop innovative treatment protocols, and contribute to advancements in cancer research. It has established partnerships with international pharmaceutical and biotech companies to explore new treatments and therapies for cancer patients.
As a socially responsible company, Concord Medical Services Holdings Ltd actively participates in various public welfare activities and charity initiatives. It supports cancer prevention and education campaigns, provides financial aid to underprivileged patients, and organizes community health screenings to raise awareness about cancer and promote early detection.
In summary, Concord Medical Services Holdings Ltd is a leading specialized hospital management company in China that operates premium cancer hospitals and provides advanced cancer treatment and healthcare services. With a strong focus on innovation, patient-centered care, and collaboration, the company strives to make a positive impact in the field of oncology and contribute to the fight against cancer.
Concord Medical Services Holdings Ltd primarily focuses on the operation and management of radiotherapy and diagnostic imaging centers. The company's flagship brand, Concord Cancer Hospital, offers comprehensive cancer treatment and diagnostic services. It collaborates with renowned domestic and international hospitals and medical institutions to provide patients with cutting-edge medical technologies and treatment options.
The company's business model involves leasing or acquiring medical equipment and diagnostic machines, which it then operates and manages in its hospitals and centers. It also provides technical support, training, and consulting services to its partner hospitals, thereby promoting the adoption of advanced medical technologies and best practices in the industry.
Concord Medical Services Holdings Ltd owns and operates a network of hospitals and centers across major cities in China, including Beijing, Shanghai, and Guangzhou. These facilities are staffed by highly trained medical professionals, including doctors, nurses, and technicians, who specialize in cancer treatment and care. The company ensures that its hospitals and centers are equipped with state-of-the-art medical equipment and technologies to deliver precise and effective treatment to its patients.
In addition to its hospital management services, Concord Medical Services Holdings Ltd operates a patient-centered healthcare ecosystem. This ecosystem integrates online and offline healthcare services to provide patients with a convenient and comprehensive healthcare experience. Through its online platform, patients can access medical information, make appointments, receive telemedicine consultations, and order medicines or medical supplies.
Furthermore, Concord Medical Services Holdings Ltd actively engages in medical research and development. The company collaborates with renowned medical institutions, universities, and research organizations to conduct clinical trials, develop innovative treatment protocols, and contribute to advancements in cancer research. It has established partnerships with international pharmaceutical and biotech companies to explore new treatments and therapies for cancer patients.
As a socially responsible company, Concord Medical Services Holdings Ltd actively participates in various public welfare activities and charity initiatives. It supports cancer prevention and education campaigns, provides financial aid to underprivileged patients, and organizes community health screenings to raise awareness about cancer and promote early detection.
In summary, Concord Medical Services Holdings Ltd is a leading specialized hospital management company in China that operates premium cancer hospitals and provides advanced cancer treatment and healthcare services. With a strong focus on innovation, patient-centered care, and collaboration, the company strives to make a positive impact in the field of oncology and contribute to the fight against cancer.
Concord Medical Services Holdings Ltd is primarily focused on providing advanced cancer treatment services and related technologies in China. The company operates within the healthcare sector, with a particular emphasis on oncology and diagnostic imaging. Below is an extensive breakdown of the segments, products, and services offered by Concord Medical.
Segments
1. Cancer Treatment Centers:
- Concord Medical runs an extensive network of cancer treatment facilities equipped with state-of-the-art medical technologies. These centers provide comprehensive services from diagnosis to treatment and post-treatment care.
- The treatment centers are strategically located across China, making oncology care accessible to a larger population.
2. Radiotherapy Services:
- The company specializes in advanced radiotherapy techniques, including Intensity-Modulated Radiation Therapy (IMRT) and Stereotactic Radiotherapy (SRS), which allow for more precise tumor targeting while minimizing damage to surrounding healthy tissue.
- Concord Medical offers both inpatient and outpatient services, accommodating diverse patient needs.
3. Diagnostic Imaging Services:
- Concord Medical operates diagnostic imaging departments that utilize advanced imaging technologies, such as MRI, CT scans, and PET scans. These services are essential for the early detection and accurate diagnosis of cancer.
- The imaging services support the treatment workflow, providing essential information for treatment planning.
4. Training and Education:
- The company invests in training programs for healthcare professionals, focusing on the latest techniques in cancer treatment and management. This segment aims to elevate standards in oncology care and improve patient outcomes.
5. Clinical Research and Development:
- Concord Medical is involved in clinical research to advance the understanding and treatment of cancer. This includes collaboration with academic institutions and industry partners to investigate new therapies and technologies.
6. Telemedicine Services:
- In response to the shifting healthcare landscape, Concord Medical has begun integrating telemedicine solutions into its offerings. This enables remote consultations and follow-ups, thereby increasing patient convenience and access to specialists.
Products and Services
1. Advanced Cancer Treatment Solutions:
- The companys primary product is its comprehensive range of cancer treatment options, which include surgical services, chemotherapy, immunotherapy, and targeted therapy. Each treatment plan is personalized to meet the specific needs of patients.
2. Radiotherapy Systems:
- Concord Medical utilizes cutting-edge radiotherapy systems, including those from leading manufacturers, which are designed for high precision, safety, and efficiency in delivering treatment.
3. Supportive Care Services:
- Beyond direct treatment, Concord Medical offers an array of supportive care services, including pain management, psychological counseling, nutritional support, and palliative care. These services are vital in ensuring the overall well-being of patients undergoing cancer treatment.
4. Patient Management Software:
- The company has developed software solutions for patient management that facilitate efficient tracking of patient progress, treatment plans, and administrative tasks. This technology improves the operational efficiency of treatment centers.
5. Partnerships with Research Institutions:
- Through collaborations with universities and research entities, Concord Medical engages in developing innovative cancer therapies and participates in clinical trials that expand treatment options for patients.
6. Public Health Initiatives:
- Concord Medical is also involved in public health campaigns aimed at increasing awareness of cancer prevention and early detection strategies. These initiatives play a critical role in educating the public and facilitating timely medical intervention.
Conclusion
Concord Medical Services Holdings Ltd encompasses a wide range of segments, products, and services tailored to meet the comprehensive needs of cancer patients. From advanced treatment modalities to diagnostic imaging and supportive care, the company strives to deliver high-quality healthcare solutions while advancing oncology treatment through research and collaboration. The emphasis on both patient care and innovation positions Concord Medical as a key player in the healthcare landscape, particularly in the field of oncology.
Segments
1. Cancer Treatment Centers:
- Concord Medical runs an extensive network of cancer treatment facilities equipped with state-of-the-art medical technologies. These centers provide comprehensive services from diagnosis to treatment and post-treatment care.
- The treatment centers are strategically located across China, making oncology care accessible to a larger population.
2. Radiotherapy Services:
- The company specializes in advanced radiotherapy techniques, including Intensity-Modulated Radiation Therapy (IMRT) and Stereotactic Radiotherapy (SRS), which allow for more precise tumor targeting while minimizing damage to surrounding healthy tissue.
- Concord Medical offers both inpatient and outpatient services, accommodating diverse patient needs.
3. Diagnostic Imaging Services:
- Concord Medical operates diagnostic imaging departments that utilize advanced imaging technologies, such as MRI, CT scans, and PET scans. These services are essential for the early detection and accurate diagnosis of cancer.
- The imaging services support the treatment workflow, providing essential information for treatment planning.
4. Training and Education:
- The company invests in training programs for healthcare professionals, focusing on the latest techniques in cancer treatment and management. This segment aims to elevate standards in oncology care and improve patient outcomes.
5. Clinical Research and Development:
- Concord Medical is involved in clinical research to advance the understanding and treatment of cancer. This includes collaboration with academic institutions and industry partners to investigate new therapies and technologies.
6. Telemedicine Services:
- In response to the shifting healthcare landscape, Concord Medical has begun integrating telemedicine solutions into its offerings. This enables remote consultations and follow-ups, thereby increasing patient convenience and access to specialists.
Products and Services
1. Advanced Cancer Treatment Solutions:
- The companys primary product is its comprehensive range of cancer treatment options, which include surgical services, chemotherapy, immunotherapy, and targeted therapy. Each treatment plan is personalized to meet the specific needs of patients.
2. Radiotherapy Systems:
- Concord Medical utilizes cutting-edge radiotherapy systems, including those from leading manufacturers, which are designed for high precision, safety, and efficiency in delivering treatment.
3. Supportive Care Services:
- Beyond direct treatment, Concord Medical offers an array of supportive care services, including pain management, psychological counseling, nutritional support, and palliative care. These services are vital in ensuring the overall well-being of patients undergoing cancer treatment.
4. Patient Management Software:
- The company has developed software solutions for patient management that facilitate efficient tracking of patient progress, treatment plans, and administrative tasks. This technology improves the operational efficiency of treatment centers.
5. Partnerships with Research Institutions:
- Through collaborations with universities and research entities, Concord Medical engages in developing innovative cancer therapies and participates in clinical trials that expand treatment options for patients.
6. Public Health Initiatives:
- Concord Medical is also involved in public health campaigns aimed at increasing awareness of cancer prevention and early detection strategies. These initiatives play a critical role in educating the public and facilitating timely medical intervention.
Conclusion
Concord Medical Services Holdings Ltd encompasses a wide range of segments, products, and services tailored to meet the comprehensive needs of cancer patients. From advanced treatment modalities to diagnostic imaging and supportive care, the company strives to deliver high-quality healthcare solutions while advancing oncology treatment through research and collaboration. The emphasis on both patient care and innovation positions Concord Medical as a key player in the healthcare landscape, particularly in the field of oncology.